Skip to main content

Home/ Cheap Generic ED drugs/ Group items tagged Chronic

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Matilde Fernandes

Germany Drug Forecast and Market Analysis to 2022 - 0 views

www.researchongermany.com/d-market-analysis-to-2022.html

Profiles Reports Markets Market Industry Research Company supports Global rubber

shared by Matilde Fernandes on 13 Dec 13 - No Cached
  • Matilde Fernandes on 13 Dec 13
     
    The German chronic heart failure (CHF) therapeutics market was worth approximately USD 484.7 million in 2012, with a projected compound annual growth rate (CAGR) of 2.4%, to reach a total of USD 614.8 million in 2022. The launch of Novartis' novel combination drug, LCZ-696 in 2015 will mark the first entrance of a novel branded CHF drug in the past five years, boosting the overall market size considerably till 2022.
Matilde Fernandes

Global Research Reports on Vitamin D Testing Market - 0 views

research-report.ucoz.com/...2013-12-27-20

Global Vitamin D Testing market landscape growth rate in-depth analysis inputs from industry experts opportunities challenges to

shared by Matilde Fernandes on 27 Dec 13 - No Cached
  • Matilde Fernandes on 27 Dec 13
     
    The global vitamin D testing market is expected to grow at a CAGR of 32.36% over 2013 to 2018. One of the key factors contributing to this market growth is the increase in aging and chronically ill populations worldwide. This market has also been witnessing the increase in product approvals.
Matilde Fernandes

Kidney Disease Global Market Research Reports - 2 views

www.researchonglobalmarkets.com/e-pipeline-review-h1-2014.html

Kidney Disease Research Reports Therapeutic Products Chronic Polycystic

shared by Matilde Fernandes on 15 May 14 - No Cached
  • Matilde Fernandes on 15 May 14
     
    Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
1 - 3 of 3
Showing 20▼ items per page